Home

The Inverted Yield Curve as an Accurate Predictor of Recession

Based on our team's analysis, if you look at the 5-year versus the 2-year bond spread, the yield cur…

Bitcoin at All-Time Lows: Time to Buy, Says Bitcoin Experts…

Bitcoin will mint new millionaires in 2019 …

What About the New 52-Week High Mark for a Stock?

For the short-term minded trader who elects to buy the stock as a result of its 52-week outstanding …

Meridian Bioscience, Inc., Stock (VIVO) in Spot Light Today After FDA Granted Marketing Authorization of Alethia CMV Assay Test System to the Company

According to the Centers for Disease Control and Prevention, more than half of adults by age 40 have…

Fastest Way to Make Short-Term Profits in the Stock Market is Shorting Stocks

My discovery explains the reason why most traders lose money in the stock market. Those losing trade…

FDA Warns Consumers to Avoid Rhino Male Enhancement Products Found at Gas Station Retailers because of Undeclared and Potentially Dangerous Drug Ingredients

The FDA has received reports of people experiencing chest pain, severe headaches and prolonged erect…

SEC Settles Insider Trading Claims Against Former Chairman and CEO of Advanced Medical Optics

The SEC's complaint alleged that in October 2008 Mazzo executed a nondisclosure agreement with Abbot…

Investor Testing of the Proposed Relationship Summary for Investment Advisers and Broker-Dealers

Testing Investors on How Well They Know About Activities of Financial or Investment Advisors and Bro…

Pfizer Stock (PFE) on Investor Radar Today, Nov 23, 2018, After FDA Approval of Its Acute Myeloid Leukemia Drug Daurismo (glasdegib)

The FDA granted the approval of Daurismo to Pfizer... …

Restore Bio Inc., Stock (TORC) Up Over 6% On Positive FDA Phase 2b Trial News for RTB101 Potential in Reducing Incidence of Respiratory Track Infections in Elderly Patients and Third Quarter 2018 Financial Results

Restorbio Reports Third Quarter 2018 Financial Results Nov 13, 2018 and FDA phase 2b postive news …

Page 1 of 812 3 4 5 » ...Last »

Fintech
Benzinga BioTech
Investment News
Stocks to Watch
Finance
Most Popular News Articles
Bitcoin News
Cramers Picks
Technology News
Stocks and Commodities
Daily Technical Analysis
CGC
Featured Stock
Emerging Markets
Economy
Investing
Options
Real Estate News
Nasdaq Stock News
Latest Articles in Real Estate
Mstardom Finance
Food and Drug Administration--Press Releases
What's New: Drugs RSS Feed
OTC Markets Group - News, Filings & Corporate Actions
ECB - European Central Bank
FRB: Press Release - All Releases
Press Releases
St. Louis Fed - Recent Research
Research Announcements – St. Louis Fed Economic Research
Economic Education
Investor Alerts and Bulletins
SEC.gov Updates: Litigation Releases
SEC.gov Updates: Proposed Rules

LexinFintech Holdings Ltd. Expects Limited Impact from P2P Regulations and Raises Loan Origination Guidance

12 December 2018 - PRNewswire

SHENZHEN, China, Dec. 12, 2018 /PRNewswire/ -- LexinFintech Holdings ...

Full story available on Benzinga.com

The Daily Biotech Pulse: Legal Victory For Boston Scientific, Alder Gets New CFO, FDA Go-Ahead For BioXcel

12 December 2018 - Shanthi Rexaline

Here's a roundup of top developments in the biotech space over the last 24 hours.

Scaling The Peak

(Biotech stocks hitting 52-week highs on Dec. 11)

Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) OvaScience Inc (NASDAQ: MLND) Osiris Therapeutics, Inc. (NASDAQ: OSIR) Down In The Dumps

(Biotech stocks hitting 52-week lows on Dec. 11)

Aptevo Therapeutics Inc (NASDAQ: APVO) Biocept Inc (NASDAQ: BIOC) BIOLASE Inc (NASDAQ: BIOL) Cidara Therapeutics Inc (NASDAQ: CDTX) Corvus Pharmaceuticals Inc (NASDAQ: CRVS) Curis, Inc. (NASDAQ: CRIS) Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) DURECT Corporation (NASDAQ: DRRX) IntelliPharmaCeutics Intl Inc(NASDAQ: IPCI) Jaguar Health Inc (NASDAQ: JAGX) Melinta Therapeutics Inc (NASDAQ: MLNT) Mesoblast limited (NASDAQ: MESO) Midatech Pharma PLC-ADR (NASDAQ: MTP) Nemaura Medical Inc (NASDAQ: NMRD) NewLink Genetics Corp (NASDAQ: NLNK) Ophthotech Corp (NASDAQ: OPHT) Ovid Therapeutics Inc (NASDAQ: OVID) Pluristem Therapeutics Inc. (NASDAQ: PSTI) Prana Biotechnology Limited (NASDAQ: PRAN) Psychemedics Corp. (NASDAQ: PMD) Reshape Lifesciences Inc (NASDAQ: RSLS) SCYNEXIS Inc (NASDAQ: SCYX) Sierra Oncology Inc (NASDAQ: SRRA) Tenax Therapeutics Inc (NASDAQ: <a ...

Full story available on Benzinga.com

Will Alphabet Stock Break Below $1,000?

11 December 2018 - Alan Farley

Tech powerhouse Alphabet has tested psychological support at $1,000 five times so far in 2018, raising the odds for an eventual breakdown.

Stocks to Watch: DuPont, Nike, KB Home are stocks to watch

27 June 2014

Among the companies whose shares are expected to see active trade in Friday’s session are DuPont, Nike, and KB Home.

Prospect Capital's Updated Dividend And NAV Sustainability Analysis - Part 1 (Includes Fiscal Year 2019 Monthly Dividend Projections)

12 December 2018

FedEx: Amazon Air Fears Are Already Priced In

12 December 2018

The Daily: CEX.io Enforces KYC, Okex Updates BCH Ticker

12 December 2018 - Avi Mizrahi

The Daily: CEX.io Makes Verification Mandatory, Okex Updates BCH Ticker In today’s edition of The Daily we cover another cryptocurrency venue that now requires verification from traders, the latest exchange to update the BCH ticker since the recent hard fork, a new solution for reporting crypto taxes for cannabis merchants, and a new way in which founders are demonstrating commitment to their crypto businesses. Also […]

The post The Daily: CEX.io Enforces KYC, Okex Updates BCH Ticker appeared first on Bitcoin News.

Traders Are Confused- Cramer's Mad Money (12/10/18)

11 December 2018

World Cup tops Google searches in 2018, tech is nowhere to be seen

12 December 2018 - Stan Schroeder

Google published its "Year in Search 2018" report on Wednesday, and unsurprisingly, the global results are topped by the biggest sporting event of the year, the World Cup. Sports, elections, catastrophes and celebrities typically dominate these lists, and the year behind us was no different.

There is one notable change compared to years past, however: Tech-related topics didn't make any of the lists.

World Cup aside, the global top list of searches is dominated by a heartbreakingly long list of celebrities who died in 2018: Avicii, Mac Miller, Stan Lee, Anthony Bourdain, XXXTentacion, Stephen Hawking and Kate Spade are all in the top ten. Black Panther and Meghan Markle (who also tops Google's "People" list this year) round up the list. Read more...

More about Google, Search, Culture, Year In Review 2018, and Tech

Elliot Wave Sell setup

12 December 2018

As those who know me at all know.. i use a lot of different tools The Pivots, EMAs, VWAP, Market Profile (price volume in different time periods), Fib analysis, etc.. but my favorite is Elliot Waves, and there is my count and then there is the count, and setups from the MTPredictor SW... This is a sell setup that appeared in the 1 hour timeframe at 6:00 AM EST today. It also appears in the 30 minute timeframe. We will see how it pans out.

Forget The Liars! Here is The Truth! Bitcoin! (BTC)

11 December 2018

Just by glancing at this chart, I can tell you will 99.999999% certainty, that BTC still has a long way to fall. Sure, it could rally and fall and rally and fall, but the end result is going to be BTC at or below $1100. There is a saying on Wall St. that I have cited many times as an analyst here, but it applies now more than ever. "Never try to catch a falling knife." This market is a falling knife. If you go long, you're attempting to catch that falling knife, and when you do that your hand usually gets impaled. What you are looking at, is a classic bubble meltdown. You can disagree if you want, but that is a fact of this market, and I've been saying it for months and months — often in the face of mass rejection. I don't normally do macro analyses such as this, but it's very evident, and this simple analysis ties in nicely with the last macro analysis that I did, showing that BTC is still far above it's average historical price. In the recent log analysis that I did, I gave a very strong technical argument for why BTC is poised to fall to at least $1175, should it repeat it's historical price movement, which appears to be happening. However, ANYONE, and I mean ANYONE, who tells you that the bottom is in, at this point in the market cycle, is leading you toward extreme financial danger. Just look at it. Doe's it look like, overall, we're heading higher, or lower? I'm not asking if you think a rally is going to happen. I'm asking from a macro, longer-term perspective. Because, to me, it looks like well into 2019, BTC will continue to fizzle out, as it grinds toward the ground it once lied on. Rallies will happen, and they might be quite significant, but they will still fall short, and BTC will most likely return to a long drawn out cycle of nothingness. Now, after that cycle of nothingness, things could liven up again, and who knows, we may see higher highs in the market. But I can say with nearly 100% certainty, that it's not going to happen anytime soon, IF it happens at all. I'm the master of the charts, the professor, the legend, the king, and I go by the name of Magic! Au revoir. ***This information is not a recommendation to buy or sell. It is to be used for educational purposes only.*** -JD-

CGC potential daily lower high on watch

9 December 2018

Watching CGC first thing Monday to see if the high of Friday or the low of Friday breaks to signal sort term direction

Morning Technical Newsletter APPLE

11 December 2018

Intraday target: $167 Long-term target: $100

The Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest

11 December 2018

For Immediate Release Chicago IL December 11 2018 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog

Wall Street points to higher open; Dow futures jump 200 points

22 February 2016

Investing.com Investing.com U.S. stock markets pointed to strong gains at the open on Monday, with the Dow futures briefly jumping more than 200 points as a rebound in oil prices boosted market sentiment. The blue chip Dow futures climbed

Chinese Imports and Exports Decline Big in November

10 December 2018

We start a new week of trading waking up to lower market closes across the Pacific with Asian indexes like the Nikkei in Japan 2 and Hong Kong 1 2 This came on the heels of big drops in Chinese imports and exports which fell precipitously from the month of October to November

BRT Realty (BRT) Beats Q4 FFO and Revenue Estimates

11 December 2018

BRT Realty BRT came out with quarterly funds from operations FFO of 0 21 per share beating the Zacks Consensus Estimate of 0 20 per share This compares to FFO of 0 22 per share a year ago These figures are adjusted for non recurring items This quarterly report represents an FFO

Volatility Reigns as Stocks Finish Higher, Erase Steep Losses

10 December 2018

It was a volatile day on Wall Street with the Dow and S amp P 500 ultimately finishing in the black and snapping their three day losing streak The blue chip index was down 507 points at its session lows and briefly breached the 24 000 level but erased those steep losses in

Apple in 2018: Hitting $1 Trillion, Buybacks, and iPhone Concerns

11 December 2018

It s been quite a year for Apple NASDAQ AAPL one marked by meaningful milestones and progress on fundamental goals Recent market volatility however has led Apple shares to give up all of their gains for the year much like the broader market Let s take a look at Apple s

8 Steps To Take As Executor Of Parents' Estate

10 December 2018

By Dave Rowan, CFP® Being named the executor of your parents’ estate is a great honor. Your duty as executor is ultimately to carry out the final wishes of the deceased. While this can be a lot of work, it can also be rewarding to know that you are serving in this important role. If you have been named the

The Inverted Yield Curve as an Accurate Predictor of Recession

6 December 2018 - Glenford Robinson

Based on our team's analysis, if you look at the 5-year versus the 2-year bond spread, the yield curve looks like it's in neutral territory; it's on its way to inverting, but that's still a while off.

FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications

11 December 2018

FDA update on the ongoing investigation into angiotensin II receptor blocker impurities, recalls and current findings.

Newly Added Guidance Documents

12 December 2018

Guidance documents represent the FDA's current thinking on a particular subject. New guidance documents are listed here for three months.

CytoDyn Inc. (CYDY: OTCQB) | CytoDyn Appoints Dr. Scott A. Kelly as Chairman of the Board

12 December 2018

Benoît Cœuré: Euro Cyber Resilience Board for pan-European Financial Infrastructures

7 December 2018

Federal Reserve Board announces approval of proposals by Synovus Financial Corp. and Synovus Bank

7 December 2018

Federal Reserve Board announces approval of proposals by Synovus Financial Corp. and Synovus Bank

SEC Names Danae M. Serrano Acting Ethics Counsel and Designated Agency Ethics Official

11 December 2018

The Securities and Exchange Commission today announced that Danae M. Serrano has been named Acting Ethics Counsel and Designated Agency Ethics Official. Ms. Serrano joined the SEC in 2010 as an Assistant Ethics Counsel, and has served as the Deputy Ethics Counsel and Alternate Designated Agency Ethics Official since 2013. Ms. Serrano also served as the Agency’s Acting Chief Compliance Officer until August 2018. “Danae is widely respected by her colleagues throughout the Commission for her steady and thoughtful ethics counsel,” said Chairman Jay Clayton. “I know that Danae and her team are committed to maintaining the highest ethical standards at the SEC, and I want to thank her for taking on this important role in support of the Commission and our dedicated staff.” “I am grateful for this opportunity to lead the talented and dedicated staff in the Office of the Ethics Counsel, and for the Chairman’s support of the SEC’s robust ethics and compliance programs,” said Ms. Serrano. Before joining the SEC, Ms. Serrano served as an attorney in the General Counsel’s Office of the Pension Benefit Guaranty Corporation (PBGC), where she advised on government ethics and administrative law matters. Prior to PBGC, Ms. Serrano served as an attorney and ethics official in the United States Air Force, Office of the General Counsel. Ms. Serrano received her law degree from the University of Connecticut School of Law, where she was an Executive Editor of the Connecticut Insurance Law Journal. She received her B.A. in History from Yale University.

Individual Income Tax: The Basics and New Changes

7 December 2018

By Jeannette N. Bennett in Page One Economics®. Income tax is certain, but do you know the facts? Learn the basics of federal individual income tax and the new changes from the 2017 Tax Cuts and Jobs Act in the December 2018 issue of Page One Economics®: Focus on Finance.

Macro Connections

11 December 2018

Economic Synopses covers highly connected industries, like construction.

2019 AP Economics Conference

12 July 2019

Are you a seasoned AP economics instructor, new to teaching AP econ courses, or simply contemplating teaching them? If so, join us as Federal Reserve economists, AP economics exam readers, exam developers and instructors, and St. Louis Fed economic education staff present a program packed with the information you need to be successful.

Investor Alert: Scammers May Try to Take Advantage of the California Wildfires

29 November 2018

The SEC’s Office of Investor Education and Advocacy is issuing this Investor Alert to warn investors, including individuals who may receive lump sum payouts from insurance companies and others as a result of damage from the California wildfires, about fraudulent investment scams.

Rajeshwar R. Gannamaneni, Deepthi Gandra, and Linga R. Gannamaneni

10 December 2018

SEC Halts Alleged Insider Trading Ring Spanning Three Countries

Updated Disclosure Requirements and Summary Prospectus for Variable Annuity and Variable Life Insurance Contracts

30 October 2018

The Inverted Yield Curve as an Accurate Predictor of Recession

Based on our team’s analysis, if you look at the 5-year versus the 2-year bond spread, the yield curve looks like it’s in neutral territory; it’s on its way to inverting, but that’s still a while off.

Bitcoin at All-Time Lows: Time to Buy, Says Bitcoin Experts…

Bitcoin will mint new millionaires in 2019

What About the New 52-Week High Mark for a Stock?

For the short-term minded trader who elects to buy the stock as a result of its 52-week outstanding performance, short-term trouble could be on the horizon. The main reason why there could be trouble is because professional and institutional traders use a stock’s 52-week high mark has a take-profit point where they lock in their gains accrued over the past year.

Meridian Bioscience, Inc., Stock (VIVO) in Spot Light Today After FDA Granted Marketing Authorization of Alethia CMV Assay Test System to the Company

According to the Centers for Disease Control and Prevention, more than half of adults by age 40 have been infected with CMV. Most people infected with CMV show no signs or symptoms of infection. However, CMV infection can cause serious health problems for people with weakened immune systems and for some newborns.

Fastest Way to Make Short-Term Profits in the Stock Market is Shorting Stocks

My discovery explains the reason why most traders lose money in the stock market. Those losing traders just approach the market the wrong way. First, one must understand that what goes up must come down to some degree because profit has to be made by traders. However, what goes down doesn’t necessarily mean that it will come back up at all. That is because companies do run out of business, which cause their stock prices to plummet without recovery.